PTC Therapeutics (PTCT) Insider Trading & Ownership → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free PTCT Stock Alerts $33.62 -0.54 (-1.58%) (As of 05/2/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability PTC Therapeutics (NASDAQ:PTCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$198,737.00Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$2.67 M Get PTCT Insider Trade Alerts Want to know when executives and insiders are buying or selling PTC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PTCT Insider Buying and Selling by Quarter Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... PTC Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/19/2024Matthew B KleinCEOSell3,361$24.89$83,655.29 4/17/2024Eric PauwelsCEOSell787$25.14$19,785.18 4/2/2024Lee Scott GoldenEVPSell526$28.37$14,922.62 1/30/2024Christine Marie UtterCAOSell318$27.25$8,665.50 1/30/2024Mark Elliott BouldingVPSell794$27.25$21,636.50 1/30/2024Neil Gregory AlmsteadInsiderSell618$27.25$16,840.50 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/22/2024Allan Steven JacobsonDirectorSell10,000$27.38$273,800.00 1/8/2024Christine Marie UtterCAOSell1,188$28.64$34,024.32 1/8/2024Eric PauwelsInsiderSell1,569$28.64$44,936.16 1/8/2024Mark Elliott BouldingVPSell1,457$28.64$41,728.48 1/8/2024Matthew B KleinCEOSell2,237$28.64$64,067.68 1/8/2024Michael SchmertzlerDirectorSell1,500$27.81$41,715.00 1/5/2024Matthew B KleinCEOSell10,107$27.15$274,405.05 12/12/2023Pierre GravierCFOBuy7,700$25.81$198,737.00 9/6/2023Alethia YoungDirectorSell11,666$39.86$465,006.76 5/11/2023Allan Steven JacobsonDirectorSell23,000$55.08$1,266,840.00 (Data available from 1/1/2013 forward) PTCT Insider Trading Activity - Frequently Asked Questions Who is on PTC Therapeutics's Insider Roster? The list of insiders at PTC Therapeutics includes Alethia Young, Allan Steven Jacobson, Christine Marie Utter, David P Southwell, Dawn Svoronos, Emily Luisa Hill, Emma Reeve, Eric Pauwels, Lee Scott Golden, Mark Elliott Boulding, Matthew B Klein, Michael Schmertzler, Neil Gregory Almstead, Pierre Gravier, Stephanie Okey, and Stuart Walter Peltz. Learn more on insiders at PTCT. What percentage of PTC Therapeutics stock is owned by insiders? 5.30% of PTC Therapeutics stock is owned by insiders. Learn more on PTCT's insider holdings. Which PTC Therapeutics insiders have been buying company stock? The following insider purchased PTCT shares in the last 24 months: Pierre Gravier ($198,737.00). How much insider buying is happening at PTC Therapeutics? Insiders have purchased a total of 7,700 PTCT shares in the last 24 months for a total of $198,737.00 bought. Which PTC Therapeutics insiders have been selling company stock? The following insiders have sold PTCT shares in the last 24 months: Alethia Young ($465,006.76), Allan Steven Jacobson ($1,540,640.00), Christine Marie Utter ($1,789,819.91), David P Southwell ($1,162,900.42), Emily Luisa Hill ($418,274.36), Emma Reeve ($238,256.40), Eric Pauwels ($136,960.42), Lee Scott Golden ($14,922.62), Mark Elliott Boulding ($3,422,384.44), Matthew B Klein ($615,145.76), Michael Schmertzler ($41,715.00), Neil Gregory Almstead ($63,658.94), Stephanie Okey ($118,519.52), and Stuart Walter Peltz ($257,406.01). How much insider selling is happening at PTC Therapeutics? Insiders have sold a total of 224,852 PTC Therapeutics shares in the last 24 months for a total of $10,285,610.56 sold. More Insider Trading Tools from MarketBeat Related Companies: MRVI Insider Selling NAMS Insider Selling GERN Insider Selling KROS Insider Selling AMPH Insider Selling RNA Insider Selling SDGR Insider Selling AGIO Insider Selling SNDX Insider Selling RCKT Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NASDAQ:PTCT) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressYour bank is lying to you.MyBankTrackerTrump just won 2024Porter & CompanyA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap Profits4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PTC Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.